ShORe Phase 3 topline results accelerated; trial did not meet primary endpoint of mean change in BCVA from baseline to week 52Opthea and DFA ...
The biggest announcement from last week’s Nintendo Direct is not what you might think, but it could have a big influence on the Switch 2.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback